[go: up one dir, main page]

DE50203158D1 - DNA EXPRESSION CONSTRUCT FOR THE TREATMENT OF INFECTIONS WITH LEISHMANIOSIS - Google Patents

DNA EXPRESSION CONSTRUCT FOR THE TREATMENT OF INFECTIONS WITH LEISHMANIOSIS

Info

Publication number
DE50203158D1
DE50203158D1 DE50203158T DE50203158T DE50203158D1 DE 50203158 D1 DE50203158 D1 DE 50203158D1 DE 50203158 T DE50203158 T DE 50203158T DE 50203158 T DE50203158 T DE 50203158T DE 50203158 D1 DE50203158 D1 DE 50203158D1
Authority
DE
Germany
Prior art keywords
leishmaniosis
infections
treatment
expression construct
dna expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE50203158T
Other languages
German (de)
Inventor
Lopez Fuertes
Marcos Timon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mologen AG
Original Assignee
Mologen AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mologen AG filed Critical Mologen AG
Priority to DE50203158T priority Critical patent/DE50203158D1/en
Priority claimed from PCT/DE2002/003799 external-priority patent/WO2003031470A2/en
Application granted granted Critical
Publication of DE50203158D1 publication Critical patent/DE50203158D1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE50203158T 2001-10-02 2002-10-02 DNA EXPRESSION CONSTRUCT FOR THE TREATMENT OF INFECTIONS WITH LEISHMANIOSIS Expired - Lifetime DE50203158D1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE50203158T DE50203158D1 (en) 2001-10-02 2002-10-02 DNA EXPRESSION CONSTRUCT FOR THE TREATMENT OF INFECTIONS WITH LEISHMANIOSIS

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10148732 2001-10-02
DE10156679A DE10156679A1 (en) 2001-10-02 2001-11-12 Genetic vaccine against Leishmania major
DE50203158T DE50203158D1 (en) 2001-10-02 2002-10-02 DNA EXPRESSION CONSTRUCT FOR THE TREATMENT OF INFECTIONS WITH LEISHMANIOSIS
PCT/DE2002/003799 WO2003031470A2 (en) 2001-10-02 2002-10-02 Dna-expression construct for treatment of infections with leishmaniasis

Publications (1)

Publication Number Publication Date
DE50203158D1 true DE50203158D1 (en) 2005-06-23

Family

ID=7701212

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10156679A Ceased DE10156679A1 (en) 2001-10-02 2001-11-12 Genetic vaccine against Leishmania major
DE50203158T Expired - Lifetime DE50203158D1 (en) 2001-10-02 2002-10-02 DNA EXPRESSION CONSTRUCT FOR THE TREATMENT OF INFECTIONS WITH LEISHMANIOSIS

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10156679A Ceased DE10156679A1 (en) 2001-10-02 2001-11-12 Genetic vaccine against Leishmania major

Country Status (1)

Country Link
DE (2) DE10156679A1 (en)

Also Published As

Publication number Publication date
DE10156679A1 (en) 2003-04-30

Similar Documents

Publication Publication Date Title
DE602004028763D1 (en) TE FOR THE TREATMENT OF VIRUS DISEASES
ATE556059T1 (en) PYRAZOLE DERIVATIVES FOR THE TREATMENT OF HIV
ATE451921T1 (en) PHENYLINDOLES FOR THE TREATMENT OF HIV
DE60124302D1 (en) THIAZONE DERIVATIVES FOR THE TREATMENT OF PPAR-LIFE DISEASES
DE60113496D1 (en) Use of glycyrrhizin for the treatment of mastitis.
ATE384522T1 (en) MEDICATIONS FOR THE CHEMOTHERAPEUTIC TREATMENT OF DISEASES
DE602004022061D1 (en) USE OF MODIFIED CYCLOSPORINES FOR THE TREATMENT OF HCV DISEASES
DE602004026891D1 (en) TLR7 LIGANDS FOR THE TREATMENT OF HEPATITIS C
DE602004020901D1 (en) System for the introduction of several medical devices
DE602004020072D1 (en) 1,2,3,4-TETRASUBSTITUTED INDOL FOR THE TREATMENT OF RESPIRATORY DISEASES
EP1534074A4 (en) COMBINATION THERAPY FOR THE TREATMENT OF FATIBILITY
DE60238576D1 (en) Composition for the production of electrodes and electrodes
ATE410430T1 (en) 2,3-DIHYDRO-6-NITROIMIDAZOÄ2,1-BUOXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS
DE60222644D1 (en) PROCESS FOR THE MANUFACTURE OF TRANSPARENT FORM PARTS
DE60136477D1 (en) RETINOIDES FOR THE TREATMENT OF EMPHYSEM
DE60204466D1 (en) INTEGRINMA TREATMENT FOR THE TREATMENT OF EYE DISEASES
ATE346614T1 (en) VAGINAL COMPOSITION CONTAINING LIDOCAINE FOR THE TREATMENT OF TERMERIC RHYTHM DISORDER
ATE443704T1 (en) PYRIDOPYRIMIDINONE FOR THE TREATMENT OF CANCER DISEASES
DE60201498D1 (en) IMPROVED CARBAPENEME PRODUCTION PROCESS
DE60208738D1 (en) Process for the preparation of chlorofluoropolyoxyalkylenols
ATE372118T1 (en) THE USE OF ROSIGLITAZONE FOR THE TREATMENT OF PSYCHIATRIC DISEASES.
DE60214355D1 (en) EXEMESTAN FOR THE TREATMENT OF HORMONE-RELATED DISORDER
DE60206289D1 (en) USE OF BIBN4096 IN COMBINATION WITH OTHER MIGRANTS FOR THE TREATMENT OF MIGRAINE
DE50105735D1 (en) CHLOROZAZAZONE FOR THE TREATMENT OF PSORIASIS
DE60300252D1 (en) Process for the industrial preparation of 5-amino-3-carboxymethyl-4-cyano-2-thiphencarboxydimethylester

Legal Events

Date Code Title Description
8364 No opposition during term of opposition